Welcome to our team!

We are honoured to be joined by Kurt Ceuppens as Director Regulatory Affairs & Portfolio.

Market Access requires a holistic approach

Obtaining a price and reimbursement is often quite a challenge for innovative medicines. This requires a holistic approach by a cross-functional team and an open dialogue with all relevant stakeholders.

More explanation by Sven Tops and Frank Vanderdonck, Managing Partners at AxTalis